Enzon Pharmaceuticals Short Interest Ratio and Short Volume

Short interest is the volume of Enzon Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of January 29th, traders have sold 44,400 shares of ENZN short.

Enzon Pharmaceuticals saw a increase in short interest in January. As of January 29th, there was short interest totaling 44,400 shares, an increase of 21.6% from the previous total of 36,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.00% of Enzon Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sub-industry of "biotechnology" compare to Enzon Pharmaceuticals: Amgen Inc. (1.31%), Gilead Sciences, Inc. (1.73%), Vertex Pharmaceuticals Incorporated (0.00%), Regeneron Pharmaceuticals, Inc. (1.90%), Biogen Inc. (2.41%), Alexion Pharmaceuticals, Inc. (2.00%), Seagen Inc. (0.00%), Exact Sciences Co. (0.00%), Alnylam Pharmaceuticals, Inc. (0.00%), and Incyte Co. (0.00%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Aon Plc ($5.34 billion), Charter Communications, Inc. ($5.03 billion), ViacomCBS Inc. ($4.99 billion), DuPont de Nemours, Inc. ($4.72 billion), Analog Devices, Inc. ($4.57 billion), Snap Inc. ($3.87 billion), Moderna, Inc. ($3.58 billion), Futu Holdings Limited ($2.75 billion), Snowflake Inc. ($2.43 billion), and Palantir Technologies Inc. ($2.18 billion). View all of the most shorted stocks.

Short selling ENZN is an investing strategy that aims to generate trading profit from Enzon Pharmaceuticals as its price is falling. Enzon Pharmaceuticals' stock is trading down $0.02 today. To short Enzon Pharmaceuticals stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Enzon Pharmaceuticals will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Enzon Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ENZN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENZN, twice per month. The most recent reporting period available is January, 29 2021.